RPS6KA6 has been significantly down-regulated in colorectal cancer [62], ovarian cancer [63], non-small cell lung cancer [64], breast cancer, acute myeloid leukemia [65], etc., while this study is the first to mention that RPS6KA6 is significantly down-regulated in PTC. Here, RPS6KA6 is linked to breast carcinoma.